With $21 million in new funding from the NIAID, the network now includes eight centers in North America and will study adolescent lung transplant recipients as well as adult.

Nick Heaton, PhD, has turned his research focus from influenza to another RNA virus: COVID-19. He is using powerful gene-editing tools to identify candidates for host-directed therapeutics, which don’t attack the virus directly but instead target proteins the virus needs.

The stress and isolation of the pandemic may have a lasting toll on some children, but Duke experts say most will recover fully — and some might even emerge with new strengths.

Vaccines are our best defense against COVID-19 and its variants. Protect yourself and others - don’t wait to vaccinate!

Dr. Viviana Martinez-Bianchi, associate professor in Duke’s Department of Family Medicine and Community Health, has been named North Carolina's 2021 Family Physician of the Year by the North Carolina Academy of Family Physicians (NCAFP). The honor is the most prestigious award from the NCAFP, the state's largest specialty medical association, comprised of more than 4,300 members.

When Joe Hoffman accepted a friend’s invitation to attend the Duke Children’s Classic, he had no idea he would be starting an ongoing relationship that would last nearly 30 years and continue until today.

Race, and how people are treated differently because of it, leads to major differences in health outcomes for cancer and other diseases. As a bit of an outsider, Akinyemiju (pronounced Ah-keen-yah-MEE-jew) saw this aspect of culture and health as something to be examined and dissected. She has built her career doing that.

Duke Ph.D. students Jessica Waibl Polania (left) and Selena Lorrey are looking for ways to use the body's own immune system to target and treat glioblastoma, a particularly aggressive form of brain cancer. They are conducting their research in Peter Fecci’s lab as part of the Duke Brain Tumor Immunotherapy Program.

A new custom-developed tool, called an organ-on-a-chip, shows potential for making pre-clinical testing more accurate.

With a few large leadership gifts and some strategically placed advertising in national media, Duke University is launching a new fundraising effort designed to elevate excellence in the sciences. The faculty recruitment and retention effort, called Duke Science and Technology, will give the university resources to expand core strengths in Duke’s research, extending to nearly every corner of the university.